
Cboe Global Markets (CBOE) has reached an all-time stock high of $252.92, reflecting a 23% annual gain and robust financial health. The company reported strong Q2 2025 earnings, exceeding analyst expectations with EPS of $2.46 and revenue of $587.3 million, driven by significant growth in its Derivatives, Data Vantage, and Cash & Spot segments. This performance has prompted RBC Capital and Oppenheimer to raise their price targets, underscoring analyst confidence, though InvestingPro analysis indicates the stock is currently trading above its Fair Value.
Cboe Global Markets (CBOE) has reached a new all-time high of $252.92, a culmination of a 23% stock price increase over the past year, supported by robust fundamental performance. The company's recent Q2 2025 earnings surpassed analyst expectations, delivering an EPS of $2.46 against a $2.44 forecast and revenue of $587.3 million, which exceeded the anticipated $576.1 million. This top-line beat was driven by significant growth across key business lines, including a 17% increase in the Derivatives Markets and an 11% rise in both the Data Vantage and Cash & Spot Markets segments. Consequently, analyst sentiment is strong, with 13 analysts revising earnings expectations upward. RBC Capital raised its price target to $254, maintaining a Sector Perform rating, while Oppenheimer increased its target to $265 with an Outperform rating, both citing the strong revenue results. However, despite the positive operational momentum and a 'GOOD' financial health score, an InvestingPro analysis indicates the stock is currently trading above its Fair Value, introducing a note of caution on valuation.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment